News
Genedrive genetic variant test for infants evaluated by NICE
Genedrive – the near patient molecular diagnostics company – has revealed that the National Institute for Health and Care Excellence (NICE) has started an evaluation of the MT-RNR1 test via its Diagnostics Assessment Programme (DAP).